{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T13:08:53Z","timestamp":1754399333910},"reference-count":48,"publisher":"Akademiai Kiado Zrt.","issue":"1","content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["AMicr"],"published-print":{"date-parts":[[2019,12,13]]},"abstract":"<jats:p>Group A streptococcus (GAS) is a human pathogen causing a broad range of infections, linked with global morbidity and mortality. Macrolide resistance rates vary significantly in different parts of the world. Driving factors of the emergence and spread of resistant clones are not clearly understood. We investigated 102 macrolide-resistant GAS strains collected during the period 2014\u20132018 from various clinical specimens from Bulgarian patients. Strains were characterized by the presence of <jats:italic>mefA\/mefE, ermA<\/jats:italic>, and <jats:italic>ermB<\/jats:italic> using polymerase chain reaction and sequencing for <jats:italic>mefA\/mefE<\/jats:italic>. Resistant strains were studied by <jats:italic>emm<\/jats:italic> sequence typing and <jats:italic>emm<\/jats:italic>-cluster system. Most prevalent <jats:italic>emm<\/jats:italic> types among the macrolide-resistant GAS strains were <jats:italic>emm<\/jats:italic>28 (22.55%), <jats:italic>emm<\/jats:italic>12 (17.65%), and <jats:italic>emm<\/jats:italic>4 (16.66%). Almost all (87.25%) of the macrolide-resistant isolates harboring <jats:italic>ermB<\/jats:italic> were <jats:italic>emm<\/jats:italic>28. The isolates that carried <jats:italic>ermA<\/jats:italic> were predominantly <jats:italic>emm<\/jats:italic>12 (38.24%) and <jats:italic>emm<\/jats:italic>77 (38.24%), with fewer <jats:italic>emm<\/jats:italic>89 (23.53%). The isolates harbored predominantly <jats:italic>mefE (49 isolates)<\/jats:italic> and only 9 strains carried <jats:italic>mefA<\/jats:italic>. The most prevalent <jats:italic>emm<\/jats:italic> clusters among the GAS isolates were E4 (40.20%), A-C4 (17.65%), and E1 (16.66%). The study\u2019s results suggest that dissemination of specific clones in GAS population may also be the reason for the increasing macrolide-resistance rate in our country.<\/jats:p>","DOI":"10.1556\/030.66.2019.033","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T12:57:52Z","timestamp":1576241872000},"page":"14-17","update-policy":"http:\/\/dx.doi.org\/10.1556\/policypage.crossmark.crossref.1","source":"Crossref","is-referenced-by-count":8,"title":["Molecular emm typing of Bulgarian macrolide-resistant Streptococcus pyogenes isolates"],"prefix":"10.1556","volume":"67","author":[{"given":"Adile","family":"Muhtarova","sequence":"first","affiliation":[{"name":"1 Department of Medical Microbiology, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalina","family":"Mihova","sequence":"additional","affiliation":[{"name":"2 Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Faculty of Medicine, Medical University, Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumyana","family":"Markovska","sequence":"additional","affiliation":[{"name":"1 Department of Medical Microbiology, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Mitov","sequence":"additional","affiliation":[{"name":"1 Department of Medical Microbiology, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radka","family":"Kaneva","sequence":"additional","affiliation":[{"name":"2 Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Faculty of Medicine, Medical University, Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raina","family":"Gergova","sequence":"additional","affiliation":[{"name":"1 Department of Medical Microbiology, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"ref381","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/clinids\/5.6.1033","article-title":"Antimicrobial resistance in hospital organisms and its relation to antibiotic use","volume":"5","author":"McGowan","year":"1983","journal-title":"Rev Infect Dis"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1099\/jmm.0.000146","article-title":"Evolution of macrolide resistance in Streptococcus pyogenes over 14 years in an area of central Italy","volume":"64","author":"Olivieri","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fpubh.2018.00059","article-title":"Prevalent emm types among invasive GAS in Europe and North America since year 2000","volume":"6","author":"Gherardi","year":"2018","journal-title":"Front Public Health"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fpubh.2018.00059","article-title":"Prevalent emm types among invasive GAS in Europe and North America since year 2000","volume":"6","author":"Gherardi","year":"2018","journal-title":"Front Public Health"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1128\/JCM.00301-15","article-title":"Streptococcus pyogenes emm types and clusters during a 7-year period (2007 to 2013) in pharyngeal and nonpharyngeal pediatric isolates","volume":"53","author":"Koutouzi","year":"2015","journal-title":"J Clin Microbiol"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/clinids\/24.Supplement_1.S89","article-title":"Recent evaluation of antimicrobial resistance in \u03b2-hemolytic streptococci","volume":"24","author":"Kaplan","year":"1997","journal-title":"Clin Infect Dis"},{"key":"ref21","article-title":"Mechanisms of antibiotic resistance","volume-title":"Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]","author":"Cattoir","year":"2016"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10096-003-1069-1","article-title":"Dissemination of emm28 erythromycin-, clindamycin-and bacitracin-resistant Streptococcus pyogenes in Spain","volume":"23","author":"Perez-Trallero","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2011.09.005","article-title":"New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci","volume":"29","author":"Dale","year":"2011","journal-title":"Vaccine"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jiac.2016.06.013","article-title":"Molecular epidemiology, antimicrobial susceptibility, and characterization of macrolide-resistant Streptococcus pyogenes in Japan","volume":"22","author":"Tanaka","year":"2016","journal-title":"J Infect Chemother"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cid\/ciu304","article-title":"Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group A streptococcal infections","volume":"59","author":"Carapetis","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1093\/cid\/ciu490","article-title":"The emm-cluster typing system for group A streptococcus identifies epidemiologic similarities across the Pacific region","volume":"59","author":"Baroux","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1128\/JCM.42.8.3844-3846.2004","article-title":"Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics","volume":"42","author":"Mihaila-Amrouche","year":"2004","journal-title":"J Clin Microbiol"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/ijmm.IJMM_18_107","article-title":"Trends in antimicrobial resistance patterns of Group A streptococci, molecular basis and implications","volume":"36","author":"Abraham","year":"2018","journal-title":"Indian J Med Microbiol"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3389\/fmicb.2017.01052","article-title":"High prevalence of macrolide-resistance and molecular characterization of Streptococcus pyogenes isolates circulating in China from 2009 to 2016","volume":"8","author":"Lu","year":"2017","journal-title":"Front Microbiol"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1089\/mdr.2017.0306","article-title":"Changes in macrolide resistance among group A streptococci in Serbia and clonal evolution of resistant isolates","volume":"24","author":"Gajic","year":"2018","journal-title":"Microb Drug Resist"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/jac\/dkw116","article-title":"Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007\u201313)","volume":"71","author":"Michos","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/ijmm.IJMM_18_107","article-title":"Trends in antimicrobial resistance patterns of Group A streptococci, molecular basis and implications","volume":"36","author":"Abraham","year":"2018","journal-title":"Indian J Med Microbiol"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.otohns.2007.07.033","article-title":"Systematic review of factors contributing to penicillin treatment failure in Streptococcus pyogenes pharyngitis","volume":"137","author":"Pichichero","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1128\/JCM.00301-15","article-title":"Streptococcus pyogenes emm types and clusters during a 7-year period (2007 to 2013) in pharyngeal and nonpharyngeal pediatric isolates","volume":"53","author":"Koutouzi","year":"2015","journal-title":"J Clin Microbiol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1128\/JCM.43.8.4083-4091.2005","article-title":"Genetic diversity among type emm28 group A streptococcus strains causing invasive infections and pharyngitis","volume":"43","author":"Green","year":"2005","journal-title":"J Clin Microbiol"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/clinids\/24.Supplement_1.S89","article-title":"Recent evaluation of antimicrobial resistance in \u03b2-hemolytic streptococci","volume":"24","author":"Kaplan","year":"1997","journal-title":"Clin Infect Dis"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jgar.2017.05.026","article-title":"Distribution of macrolide resistance mechanisms in Bulgarian clinical isolates of Streptococcus pyogenes during the years of 2013\u20132016","volume":"10","author":"Muhtarova","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.otohns.2007.07.033","article-title":"Systematic review of factors contributing to penicillin treatment failure in Streptococcus pyogenes pharyngitis","volume":"137","author":"Pichichero","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10096-003-1069-1","article-title":"Dissemination of emm28 erythromycin-, clindamycin-and bacitracin-resistant Streptococcus pyogenes in Spain","volume":"23","author":"Perez-Trallero","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1128\/JCM.43.8.4083-4091.2005","article-title":"Genetic diversity among type emm28 group A streptococcus strains causing invasive infections and pharyngitis","volume":"43","author":"Green","year":"2005","journal-title":"J Clin Microbiol"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jiac.2018.10.004","article-title":"The most common causative bacteria in maternal sepsis-related deaths in Japan were group A streptococcus: A nationwide survey","volume":"25","author":"Tanaka","year":"2019","journal-title":"J Infect Chemother"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jiac.2018.10.004","article-title":"The most common causative bacteria in maternal sepsis-related deaths in Japan were group A streptococcus: A nationwide survey","volume":"25","author":"Tanaka","year":"2019","journal-title":"J Infect Chemother"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cid\/ciu304","article-title":"Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group A streptococcal infections","volume":"59","author":"Carapetis","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/infdis\/jiu260","article-title":"A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development","volume":"210","author":"Sanderson-Smith","year":"2014","journal-title":"J Infect Dis"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1128\/JCM.41.11.5282-5284.2003","article-title":"Bacitracin-resistant clone of Streptococcus pyogenes isolated from pharyngitis patients in Belgium","volume":"41","author":"Malhotra-Kumar","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1128\/JCM.42.8.3844-3846.2004","article-title":"Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics","volume":"42","author":"Mihaila-Amrouche","year":"2004","journal-title":"J Clin Microbiol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1099\/jmm.0.000146","article-title":"Evolution of macrolide resistance in Streptococcus pyogenes over 14 years in an area of central Italy","volume":"64","author":"Olivieri","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3389\/fmicb.2017.01052","article-title":"High prevalence of macrolide-resistance and molecular characterization of Streptococcus pyogenes isolates circulating in China from 2009 to 2016","volume":"8","author":"Lu","year":"2017","journal-title":"Front Microbiol"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1089\/mdr.2017.0306","article-title":"Changes in macrolide resistance among group A streptococci in Serbia and clonal evolution of resistant isolates","volume":"24","author":"Gajic","year":"2018","journal-title":"Microb Drug Resist"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jiac.2016.06.013","article-title":"Molecular epidemiology, antimicrobial susceptibility, and characterization of macrolide-resistant Streptococcus pyogenes in Japan","volume":"22","author":"Tanaka","year":"2016","journal-title":"J Infect Chemother"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1586\/14787210.2015.1023292","article-title":"Macrolide-resistant Streptococcus pyogenes: Prevalence and treatment strategies","volume":"13","author":"Silva-Costa","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1586\/14787210.2015.1023292","article-title":"Macrolide-resistant Streptococcus pyogenes: Prevalence and treatment strategies","volume":"13","author":"Silva-Costa","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/clinids\/5.6.1033","article-title":"Antimicrobial resistance in hospital organisms and its relation to antibiotic use","volume":"5","author":"McGowan","year":"1983","journal-title":"Rev Infect Dis"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/jac\/dkw116","article-title":"Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007\u201313)","volume":"71","author":"Michos","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/infdis\/jiu260","article-title":"A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development","volume":"210","author":"Sanderson-Smith","year":"2014","journal-title":"J Infect Dis"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1093\/cid\/ciu490","article-title":"The emm-cluster typing system for group A streptococcus identifies epidemiologic similarities across the Pacific region","volume":"59","author":"Baroux","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2011.09.005","article-title":"New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci","volume":"29","author":"Dale","year":"2011","journal-title":"Vaccine"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jgar.2017.05.026","article-title":"Distribution of macrolide resistance mechanisms in Bulgarian clinical isolates of Streptococcus pyogenes during the years of 2013\u20132016","volume":"10","author":"Muhtarova","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1128\/JCM.41.11.5282-5284.2003","article-title":"Bacitracin-resistant clone of Streptococcus pyogenes isolated from pharyngitis patients in Belgium","volume":"41","author":"Malhotra-Kumar","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref271","article-title":"Mechanisms of antibiotic resistance","volume-title":"Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]","author":"Cattoir","year":"2016"}],"container-title":["Acta Microbiologica et Immunologica Hungarica"],"original-title":[],"link":[{"URL":"https:\/\/www.akademiai.com\/doi\/full-xml\/10.1556\/030.66.2019.033","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/view\/journals\/030\/67\/1\/article-p14.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/030\/67\/1\/article-p14.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:25Z","timestamp":1651536025000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/030\/67\/1\/article-p14.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,13]]},"references-count":48,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1556\/030.66.2019.033","relation":{},"ISSN":["1217-8950","1588-2640"],"issn-type":[{"value":"1217-8950","type":"print"},{"value":"1588-2640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,13]]}}}